Related Experiment Video
Updated: Mar 22, 2026

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy
Published on: September 25, 2017
What Is the Effect of Metabolic Syndrome without Hypertension on Left Ventricular Hypertrophy?
Mohammad M Al-Daydamony1, Mohammad El-Tahlawi2
1Cardiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Insights
Metabolic syndrome (MetS) increases left ventricular hypertrophy (LVH) even without hypertension. MetS patients showed higher LV mass and wall thickness, linked to glucose, HbA1c, triglycerides, and obesity.
Area of Science:
- Cardiology
- Metabolic Diseases
- Clinical Research
Background:
- Left ventricular hypertrophy (LVH) is a key risk factor for cardiovascular events.
- Metabolic syndrome (MetS) is strongly linked to LVH in hypertensive individuals.
- The association between MetS and LVH without hypertension remains understudied.
Purpose of the Study:
- To investigate the impact of MetS on left ventricular (LV) mass in non-hypertensive patients.
- To determine if MetS contributes to LVH independent of elevated blood pressure.
Main Methods:
- Fifty MetS patients without hypertension and 50 healthy controls were recruited.
- Evaluations included electrocardiography, laboratory tests, and echocardiography.
- Measurements assessed LV dimensions, function, mass, and mass index (LVMI).
Main Results:
- No significant differences in LV diastolic or systolic dimensions, or ejection fraction were observed.
- MetS patients exhibited significantly higher LV posterior wall thickness, LV mass, and LVMI.
- LVMI correlated positively with glucose, HbA1c, triglycerides, and obesity, and negatively with HDL-C.
Conclusions:
- MetS is associated with increased LV wall thickness, LV mass, and LVMI, even in the absence of hypertension.
- These findings highlight MetS as an independent risk factor for LVH.
- Metabolic parameters like glucose and triglycerides are significant predictors of LVH in this population.
Background:
Left ventricular hypertrophy (LVH) is an independent risk factor for cardiovascular events. There is a strong association between metabolic syndrome (MetS) and LVH in hypertensive patients. However, the relation between LVH and MetS in the absence of hypertension has not been studied.
Aim Of The Work:
To study the impact of MetS on LV mass in patients without hypertension.
Subjects And Methods:
Fifty MetS patients without hypertension and 50 healthy control subjects were enrolled. Twelve-lead electrocardiography, laboratory testing, and echocardiography were done with assessment of the left ventricular diastolic (LVEDD) and systolic dimensions (LVESD), fraction of shortening (FS), ejection fraction (EF), Doppler-derived mitral valve flow velocity waves (E-wave, A-wave, E/A ratio), left ventricular mass and mass index (LVMI).
Results:
There was no significant difference between the two groups regarding LVEDD, LVESD, FS, EF, E-wave velocity, A-wave velocity, or E/A ratio. However, mean posterior wall thickness, IVST, LV mass, LVMI, and incidence of LVH were significantly higher in MetS patients. There was a significant positive correlation between LVMI and blood glucose level (r = 0.528, P < 0.00001), hemoglobin A1c (HbA1c) (r = 0.416, P < 0.0001), triglycerides level (r = 0.535, P < 0.00001), and obesity (r = 0.307, p = 0.0019). There was a significant negative correlation between LVMI and HDL-C level (r = -0.377, P < 0.0001). The same parameters were predictors for LVH in a logistic regression analysis.
Conclusion:
Even in the absence of hypertension, MetS patients had significantly higher LV wall thickness, LV mass and LVMI, and incidence of LVH than control subjects.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Mitral Stenosis I: Introduction
Mitral Regurgitation I: Introduction
Cardiomyopathy V: Interprofessional Care

